» Articles » PMID: 21822857

Are All Prognostic Factors in Parotid Gland Carcinoma Well Recognized?

Overview
Date 2011 Aug 9
PMID 21822857
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of his study was to assess the treatment results and prognostic factors in patients with parotid gland carcinoma. The material consisted of 109 patients treated surgically, with or without complementary radiotherapy, between 1978 and 2008 (follow-up at least 5-years). 5-year overall and disease-specific survival were observed in 57.0% of the patients and 5-year disease-free survival was achieved in 50.0%. Univariate analysis including ten clinical and pathological features to assess their prognostic value was done. Parapharyngeal space invasion, facial nerve palsy, and high grade of tumor malignancy were the factors with the highest influence on the treatment results, because their presence decreased the chance for recovery 9.8, 9.7, and 8.2 times, respectively. Histologically positive cervical lymph nodes and extraparenchymal extension were the other factors connected with poor prognosis (prognosis worse 6.7 and 5.4 times, respectively). Clinically positive cervical lymph nodes, positive/uncertain microscopic margin, involvement of the deep lobe, or the whole gland increased the risk of treatment failure 3.4, 3.1, and 2.8, respectively. The age ≥ 60 years and male gender were statistically significant factors, correlated with poor prognosis and decreased chance for recovery 2.4 and 2.6 times. T-status and clinical stage had important influence on 5-year disease-free survival rate because there were significant differences in the treatment results between individual stages. Multivariate analysis proved that the independent prognostic value, among anatomic structures involved by the neoplasm, had mandible, facial nerve, and skin infiltration. Among tumor-related factors, T-stage and grade had the statistically significant influence on treatment results, and stage and lymph nodes metastases among clinical and pathological features. These results confirm the value of actually used TNM classification (2002). Although the parapharyngeal space invasion is a factor, which seems to have a significant, poor prognostic value, it was not included in this classification.

Citing Articles

The Clinical and Surgical Characteristics of Parotid Tumors with Parapharyngeal Space Involvement-A Multicenter Experience of the Polish Salivary Network.

Stodulski D, Mikaszewski B, Witkowski P, Bartkowiak E, Pietruszewska W, Olejniczak I J Clin Med. 2024; 13(15).

PMID: 39124841 PMC: 11313215. DOI: 10.3390/jcm13154574.


Nomogram based on immune-inflammatory indicators and age-adjusted charlson comorbidity index score to predict prognosis of postoperative parotid gland carcinoma patients.

Cheng H, Xu J, He J, Wu C, Li J, Xu X BMC Oral Health. 2024; 24(1):718.

PMID: 38909208 PMC: 11193213. DOI: 10.1186/s12903-024-04490-5.


Impact of Changing Surgical Strategies on Clinical Outcomes in Patients with Parotid Carcinoma: A 53-Year Single-Institution Experience.

Yamamoto H, Kojima T, Okanoue Y, Otsuki S, Hasebe K, Yuki R Medicina (Kaunas). 2021; 57(8).

PMID: 34440951 PMC: 8399018. DOI: 10.3390/medicina57080745.


Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.

Xu F, Feng X, Zhao F, Huang Q, Han D, Li C Cancer Med. 2021; 10(11):3756-3769.

PMID: 33960711 PMC: 8178487. DOI: 10.1002/cam4.3919.


Margin status, local control, and disease-specific survival in surgically resected parotid carcinomas with parapharyngeal extension.

Li H, McGill M, Putri N, Yuan A, Wong R, Patel S Head Neck. 2021; 43(9):2644-2654.

PMID: 33931905 PMC: 9361426. DOI: 10.1002/hed.26730.


References
1.
Armstrong J, Harrison L, Thaler H, Fass D, Zelefsky M, Shah J . The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992; 69(3):615-9. DOI: 10.1002/1097-0142(19920201)69:3<615::aid-cncr2820690303>3.0.co;2-9. View

2.
Carrillo J, Vazquez R, Ramirez-Ortega M, Cano A, Ochoa-Carrillo F, Onate-Ocana L . Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer. 2007; 109(10):2043-51. DOI: 10.1002/cncr.22647. View

3.
Carinci F, Farina A, Pelucchi S, CALEARO C, FINI-STORCHI O, Merlo R . Parotid gland carcinoma: 1987 and 1997 UICC T classifications compared for prognostic accuracy at 5 years. Eur Arch Otorhinolaryngol. 2001; 258(3):150-4. DOI: 10.1007/s004050100313. View

4.
Vander Poorten V, Balm A, Hilgers F, Tan I, Keus R, van Leeuwen F . The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999; 85(9):2057-67. View

5.
Vander Poorten V, Hart A, Vauterin T, Jeunen G, Schoenaers J, Hamoir M . Prognostic index for patients with parotid carcinoma: international external validation in a Belgian-German database. Cancer. 2009; 115(3):540-50. DOI: 10.1002/cncr.24015. View